G-CSF in healthy allogeneic stem cell donors

Transfusion Medicine and Hemotherapy

Volumn 40, Issue 4, 2013, Pages 225-235

  Hölig, Kristina ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

CD34+ cells; Donors; G CSF; Hematopoietic stem cells; Leukapheresis product

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; HEMOGLOBIN; IBUPROFEN; LACTATE DEHYDROGENASE; PARACETAMOL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; URIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR;

ABDOMINAL INJURY; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT RESPIRATORY DISTRESS SYNDROME; ALKALINE PHOSPHATASE BLOOD LEVEL; ALLOGENEIC STEM CELL TRANSPLANTATION; ALLOTRANSPLANTATION; AMINOTRANSFERASE BLOOD LEVEL; ANOREXIA; BASAL CELL CARCINOMA; BLOOD DONOR; BODY MASS; BODY TEMPERATURE; BODY WEIGHT; BONE PAIN; BRAIN TUMOR; BREAST CANCER; BURST FORMING UNIT; CELL PROLIFERATION; CELL STIMULATION; CEREBROVASCULAR ACCIDENT; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL CHEMISTRY; COHORT ANALYSIS; CONFLICT OF INTEREST; CONTACT SPORT; CYTOMEGALOVIRUS; DEEP VEIN THROMBOSIS; ELECTROCARDIOGRAM; EPSTEIN BARR VIRUS; FLU LIKE SYNDROME; FOLLOW UP; GENE EXPRESSION; GENETIC POLYMORPHISM; HEADACHE; HEALTH STATUS; HEMOGLOBIN BLOOD LEVEL; HODGKIN DISEASE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HYPERCOAGULABILITY; IN VITRO STUDY; INSOMNIA; INTERSTITIAL PNEUMONIA; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKAPHERESIS; LEUKOCYTE COUNT; LUNG CARCINOMA; LUNG FIBROSIS; LUNG INFILTRATE; LYMPHOCYTE COUNT; MALAISE; MEDICAL HISTORY; MELANOMA; MYALGIA; NAUSEA; NIGHT SWEAT; PERIPHERAL BLOOD STEM CELL; PREGNANCY TEST; PROSPECTIVE STUDY; RECTUM CARCINOMA; REVIEW; SELF EVALUATION; SEMINOMA; SEVERE CONGENITAL NEUTROPENIA; SPLEEN RUPTURE; SPLENOMEGALY; STEM CELL MOBILIZATION; SYPHILIS; TESTIS CARCINOMA; THROMBOCYTE COUNT; THYROID CARCINOMA; TOXOPLASMOSIS; UNRELATED DONORS; URIC ACID BLOOD LEVEL; URINALYSIS; UTERINE CERVIX CARCINOMA; VOMITING; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOOD CELL COUNT; DONOR SELECTION; DOSE RESPONSE; HEMATOPOIETIC STEM CELL; HUMAN CELL; NORMAL HUMAN; PATIENT SAFETY; T LYMPHOCYTE;

EID: 84883467932     PISSN: 16603796     EISSN: 16603818     Source Type: Journal    
DOI: 10.1159/000354196     Document Type: Review

References (80)

1. Bensinger WI, Clift R, Martin P, Appelbaum FR, Demirer T, Gooley T, Lilleby K, Rowley S, Sanders J, Storb R, Buckner CD: Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood 1996;88:2794-2800.
2. Ringden O, Hagglund H, Runde V, Basu O, Kroschinsky F, Stockschlader M, Potter MN: Faster engraftment of peripheral blood progenitor cells compared to bone marrow from unrelated donors. Bone Marrow Transplant 1998;21:S81-S84.
3. Thomas ED, Storb R: Technique for human marrow grafting. Blood 1970;36:507-515.
4. Baumann I, Testa NG, Lange C, de WE, Luft T, Dexter TM, van Hoef ME, Howell A: Haemopoietic cells mobilised into the circulation by lenograstim as alternative to bone marrow for allogeneic transplants. Lancet 1993;341:369.
5. Dreger P, Haferlach T, Eckstein V, Jacobs S, Suttorp M, L fler H, Muller-Ruchholtz W, Schmitz N: G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br J Haematol 1994;87:609-613.
6. Bensinger WI, Weaver CH, Appelbaum FR, Rowley S, Demirer T, Sanders J, Storb R, Buckner CD: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995;85: 1655-1658.
7. Gratwohl A, Baldomero H, Gratwohl M, Aljurf MD, Bouzas LF, Horowitz M, Kodera Y, Lipton J, Iida M, Pasquini MC, Passweg J, Szer J, Madrigal A, Frauendorfer K, Niederwieser D: Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study. Haematologica 2013;98: doi: 10.3324/haematol. 2012.076349.8 Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (H otherapie). Aufgestellt gem 12a u.
8. Transfusionsgesetz von der Bundes ztekammer im Einvernehmen mit dem Paul-Ehrlich-Institut. Zweite Richtlinienanpassung: 2010.
9. Bennett CL, Evens AM, Andritsos LA, Balasubramanian L, Mai M, Fisher MJ, Kuzel TM, Angelotta C, McKoy JM, Vose JM, Bierman PJ, Kuter DJ, Trifilio SM, Devine SM, Tallman MS: Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. Br J Haematol 2006;135:642-650.
10. Sala-Torra O, Hanna C, Loken MR, Flowers ME, Maris M, Ladne PA, Mason JR, Senitzer D, Rodriguez R, Forman SJ, Deeg HJ, Radich JP: Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006;12:511-517.
11. Gandhi MJ, Strong DM: Donor derived malignancy following transplantation: a review. Cell Tissue Bank 2007;8:267-286.
12. Niederwieser D, Gentilini C, Hegenbart U, Lange T, Moosmann P, Ponisch W, Al-Ali H, Raida M, Ljungman P, Tyndall A, Urbano-Ispizua A, Lazarus HM, Gratwohl A: Transmission of donor illness by stem cell transplantation: should screening be different in older donors Bone Marrow Transplant 2004;34:657-665.
13. Rhodes B, Anderlini P: Allogeneic peripheral blood stem cell collection as of 2008. Transfus Apher Sci 2008;38:219-227.
14. Kr er N, Zander AR: Dose and schedule effect of G-GSF for stem cell mobilization in healthy donors for allogeneic transplantation. Leuk Lymphoma 2002;43:1391-1394.
15. Grigg AP, Roberts AW, Raunow H, Houghton S, Layton JE, Boyd AW, McGrath KM, Maher D: Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood 1995;86:4437-4445.
16. Lee V, Li CK, Shing MM, Chik KW, Li K, Tsang KS, Zhao DC, Lai DH, Wong A, Yuen PM: Single vs. twice daily G-CSF dose for peripheral blood stem cells harvest in normal donors and children with non-malignant diseases. Bone Marrow Transplant 2000;25:931-935.
17. Engelhardt M, Bertz H, Afting M, Waller CF, Finke J: High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection. J Clin Oncol 1999;17: 2160-2172.
18. Sekhsaria S, Fleisher TA, Vowells S, Brown M, Miller J, Gordon I, Blaese RM, Dunbar CE, Leitman S, Malech HL: Granulocyte colony-stimulating factor recruitment of CD34+ progenitors to peripheral blood: impaired mobilization in chronic granulomatous disease and adenosine deaminasedeficient severe combined immunodeficiency disease patients. Blood 1996;88:1104-1112.
19. Stroncek DF, Clay ME, Petzoldt ML, Smith J, Jaszcz W, Oldham FB, McCullough J: Treatment of normal individuals with granulocyte-colonystimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion 1996;36:601-610.
20. Majolino I, Scime R, Vasta S, Cavallaro AM, Fiandaca T, Indovina A, Catania P, Santoro A: Mobilization and collection of PBSC in healthy donors: comparison between two schemes of rhG-CSF administration. Eur J Haematol 1996;57:214-221.
21. De la Rubia J, Martinez C, Solano C, Brunet S, Cascon P, Arrieta R, Alegre A, Bargay J, De Arriba F, Canizo C, Lopez J, Serrano D, Verdeguer A, Torrabadella M, Diaz MA, Insunza A, De la Serna J, Espigado I, Petit J, Martinez M, Benlloch L, Sanz M: Administration of recombinant human granulocyte colony-stimulating factor to normal donors: results of the Spanish National Donor Registry. Spanish Group of Allo-PBT. Bone Marrow Transplant 1999;24:723-728.
22. Murata M, Harada M, Kato S, Takahashi S, Ogawa H, Okamoto S, Tsuchiya S, Sakamaki H, Akiyama Y, Kodera Y: Peripheral blood stem cell mobilization and apheresis: analysis of adverse events in 94 normal donors. Bone Marrow Transplant 1999;24: 1065-1071.
23. Hig K, Kramer M, Kroschinsky F, Bornh ser M, Mengling T, Schmidt AH, Rutt C, Ehninger G: Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors. Blood 2009;114:3757-3763.
24. Ings SJ, Balsa C, Leverett D, Mackinnon S, Linch DC, Watts MJ: Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used. Br J Haematol 2006;134:517-525.
25. Anderlini P, Rizzo JD, Nugent ML, Schmitz N, Champlin RE, Horowitz MM: Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases. Bone Marrow Transplant 2001;27:689-692.
26. Anderlini P, Champlin RE: Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges. Blood 2008;111:1767-1772.
27. Anderlini P, Donato M, Chan KW, Huh YO, Gee AP, Lauppe MJ, Champlin RE, Korbling M: Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience. Transfusion 1999;39:555-560.
28. Anderlini P, Przepiorka D, Seong C, Smith TL, Huh YO, Lauppe J, Champlin R, Korbling M: Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim. Transfusion 1997;37:507-512.
29. De la Rubia J, Arbona C, De Arriba F, Del Canizo C, Brunet S, Zamora C, Diaz MA, Bargay J, Petit J, De la Serna J, Insunza A, Arrieta R, Pascual MJ, Serrano D, Sanjuan I, Espigado I, Alegre A, Martinez D, Verdeguer A, Martinez C, Benlloch L, Sanz MA: Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors. Transfusion 2002;42:4-9.
30. Suzuya H, Watanabe T, Nakagawa R, Watanabe H, Okamoto Y, Onishi T, Abe T, Kawano Y, Kagami S, Takaue Y: Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors. Vox Sang 2005;89:229-235.
31. Vasu S, Leitman SF, Tisdale JF, Hsieh MM, Childs RW, Barrett AJ, Fowler DH, Bishop MR, Kang EM, Malech HL, Dunbar CE, Khuu HM, Wesley R, Yau YY, Bolan CD: Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population. Blood 2008;112:2092-2100.
32. De Lavallade H, Ladaique P, Lemarie C, Furst S, Faucher C, Blaise D, Chabannon C, Calmels B: Older age does not influence allogeneic peripheral blood stem cell mobilization in a donor population of mostly white ethnic origin. Blood 2009;113:1868-1869.
33. Richa E, Papari M, Allen J, Martinez G, Wickrema A, Anastasi J, van BK, Artz A: Older age but not donor health impairs allogeneic granulocyte colony-stimulating factor (G-CSF) peripheral blood stem cell mobilization. Biol Blood Marrow Transplant 2009;15:1394-1399.
34. Al-Ali HK, Bourgeois M, Krahl R, Edel E, Leiblein S, Poenisch W, Basara N, Lange T, Niederwieser D: The impact of the age of HLA-identical siblings on mobilization and collection of PBSCs for allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2011;46:1296-1302.
35. De la Rubia J, Arbona C, Del Canizo C, Arrieta R, De Arriba F, Pascual MJ, Sanjuan I, Diaz MA, Brunet S, Alegre A, Insunza A, Espigado I, Zamora C, De la Serna J, Serrano D, Bargay J, Petit J, Martinez D, Verdeguer A, Ribera JM, Martinez C, Benlloch L, Sanz MA: Second mobilization and collection of peripheral blood progenitor cells in healthy donors is associated with lower CD34(+) cell yields. J Hematother Stem Cell Res 2002;11:705-709.
36. Platzbecker U, Bornh ser M, Zimmer K, Lerche L, Rutt C, Ehninger G, Hig K: Second donation of granulocyte-colony-stimulating factor-mobilized peripheral blood progenitor cells: risk factors associated with a low yield of CD34+ cells. Transfusion 2005;45:11-15.
37. Anderlini P, Lauppe J, Przepiorka D, Seong D, Champlin R, Korbling M: Peripheral blood stem cell apheresis in normal donors: feasibility and yield of second collections. Br J Haematol 1997;96: 415-417.
38. Benboubker L, Watier H, Carion A, Georget MT, Desbois I, Colombat P, Bardos P, Binet C, Domenech J: Association between the SDF1-3'A allele and high levels of CD34(+) progenitor cells mobilized into peripheral blood in humans. Br J Haematol 2001;113:247-250.
39. Bogunia-Kubik K, Gieryng A, Dlubek D, Lange A: The CXCL12-3'A allele is associated with a higher mobilization yield of CD34 progenitors to the peripheral blood of healthy donors for allogeneic transplantation. Bone Marrow Transplant 2009;44: 273-278.
40. Ben NM, Reguaya Z, Berraies L, Maamar M, Ladeb S, Ben OT, Mellouli F, Bejaoui M, Domenech J, Jenhani F: Association of stromal cell-derived factor-1-3'A polymorphism to higher mobilization of hematopoietic stem cells CD34+ in Tunisian population. Transplant Proc 2011;43:635-638.
41. Martin-Antonio B, Carmona M, Falantes J, Gil E, Baez A, Suarez M, Marin P, Espigado I, Urbano-Ispizua A: Impact of constitutional polymorphisms in VCAM1 and CD44 on CD34+ cell collection yield after administration of granulocyte colonystimulating factor to healthy donors. Haematologica 2011;96:102-109.
42. Halter J, Kodera Y, Ispizua AU, Greinix HT, Schmitz N, Favre G, Baldomero H, Niederwieser D, Apperley JF, Gratwohl A: Severe events in donors after allogeneic hematopoietic stem cell donation. Haematologica 2009;94:94-101.
43. Pulsipher MA, Chitphakdithai P, Logan BR, Shaw BE, Wingard JR, Lazarus HM, Waller EK, Seftel M, Stroncek DF, Lopez AM, Maharaj D, Hematti P, O'Donnell PV, Loren AW, Leitman SF, Anderlini P, Goldstein SC, Levine JE, Navarro WH, Miller JP, Confer DL: Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program. Blood 2013;121:197-206.
44. Anderlini P, Przepiorka D, Champlin R, Korbling M: Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood 1996;88:2819-2825.
45. Platzbecker U, Prange-Krex G, Bornh ser M, Koch R, Soucek S, Aikele P, Haack A, Haag C, Schuler U, Berndt A, Rutt C, Ehninger G, Hig K: Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs. Transfusion 2001; 41:184-189.
46. Stroncek D, Shawker T, Follmann D, Leitman SF: G-CSF-induced spleen size changes in peripheral blood progenitor cell donors. Transfusion 2003; 43:609-613.
47. Picardi M, De RG, Selleri C, Scarpato N, Soscia E, Martinelli V, Ciancia R, Rotoli B: Spleen enlargement following recombinant human granulocyte colony-stimulating factor administration for peripheral blood stem cell mobilization. Haematologica 2003;88:794-800.
48. Becker PS, Wagle M, Matous S, Swanson RS, Pihan G, Lowry PA, Stewart FM, Heard SO: Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells. Biol Blood Marrow Transplant 1997;3:45-49.
49. Dincer AP, Gottschall J, Margolis DA: Splenic rupture in a parental donor undergoing peripheral blood progenitor cell mobilization. J Pediatr Hematol Oncol 2004;26:761-763.
50. Nuamah NM, Goker H, Kilic YA, Dagmoura H, Cakmak A: Spontaneous splenic rupture in a healthy allogeneic donor of peripheral-blood stem cell following the administration of granulocyte colony-stimulating factor (G-CSF). A case report and review of the literature. Haematologica 2006; 91:ECR08.
51. Balaguer H, Galmes A, Ventayol G, Bargay J, Besalduch J: Splenic rupture after granulocyte-colony-stimulating factor mobilization in a peripheral blood progenitor cell donor. Transfusion 2004;44: 1260-1261.
52. Falzetti F, Aversa F, Minelli O, Tabilio A: Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healthy donor. Lancet 1999;353:555.
53. Kr er N, Renges H, Sonnenberg S, Kruger W, Gutensohn K, Dielschneider T, Cortes-Dericks L, Zander AR: Stem cell mobilisation with 16 microg/kg vs. microg/kg of G-CSF for allogeneic transplantation in healthy donors. Bone Marrow Transplant 2002;29:727-730.
54. Tigue CC, McKoy JM, Evens AM, Trifilio SM, Tallman MS, Bennett CL: Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project. Bone Marrow Transplant 2007;40:185-192.
55. Arimura K, Inoue H, Kukita T, Matsushita K, Akimot M, Kawamata N, Yamaguchi A, Kawada H, Ozak A, Arima N, Te C: Acute lung Injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone. Haematologica 2005;90:ECR10.
56. Azoulay E, Attalah H, Harf A, Schlemmer B, Delclaux C: Granulocyte colony-stimulating factor or neutrophil-induced pulmonary toxicity: myth or reality Systematic review of clinical case reports and experimental data. Chest 2001;120:1695-1701.
57. D'Souza A, Jaiyesimi I, Trainor L, Venuturumili P: Granulocyte colony-stimulating factor administration: adverse events. Transfus Med Rev 2008;22: 280-290.
58. Wetzko K, Blechschmidt M, Hig K, Poppe-Thiede K, Ganepola S, Fischbach R, Ordemann R, Laniado M, Schulte-Hubbert B, Schuler M, Cotta L, Braumann D, Ehninger G, Kroschinsky F: Pulmonary adverse events in unrelated donors of peripheral blood stem cells. Transfus Med 2013;23:69-71.
59. Falanga A, Marchetti M, Evangelista V, Manarini S, Oldani E, Giovanelli S, Galbusera M, Cerletti C, Barbui T: Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony-stimulating factor. Blood 1999;93:2506-2514.
60. Topcuoglu P, Arat M, Dalva K, Ozcan M: Administration of granulocyte-colony-stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor-dependent pathway in healthy donors. Bone Marrow Transplant 2004;33: 171-176.
61. Nomura S, Inami N, Kanazawa S, Iwasaka T, Fukuhara S: Elevation of platelet activation markers and chemokines during peripheral blood stem cell harvest with G-CSF. Stem Cells 2004;22:696-703.
62. Anderlini P: Effects and safety of granulocyte colony-stimulating factor in healthy volunteers. Curr Opin Hematol 2009;16:35-40.
63. Stroncek DF, Clay ME, Smith J, Ilstrup S, Oldham F, McCullough J: Changes in blood counts after the administration of granulocyte-colony-stimulating factor and the collection of peripheral blood stem cells from healthy donors. Transfusion 1996;36: 596-600.
64. Tassi C, Tazzari PL, Bonifazi F, Giudice V, Nannetti A, Ricci F, Rizzi S, Bandini G, Conte R: Short-and long-term haematological surveillance of healthy donors of allogeneic peripheral haematopoietic progenitors mobilized with G-CSF: a single institution prospective study. Bone Marrow Transplant 2005;36:289-294.
65. De la Rubia J, De Arriba F, Arbona C, Pascual MJ, Zamora C, Insunza A, Martinez D, Paniagua C, Diaz MA, Sanz MA: Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry. Haematologica 2008;93:735-740.
66. Anderlini P, Przepiorka D, Champlin R, Korbling M: Peripheral blood stem cell apheresis in normal donors: the neglected side. Blood 1996;88:3663-3664.
67. Sakamaki S, Matsunaga T, Hirayama Y, Kuga T, Niitsu Y: Haematological study of healthy volunteers 5 years after G-CSF. Lancet 1995;346:1432-1433.
68. Cavallaro AM, Lilleby K, Majolino I, Storb R, Appelbaum FR, Rowley SD, Bensinger WI: Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplant 2000;25:85-89.
69. Anderlini P, Chan FA, Champlin RE, Korbling M, Strom SS: Long-term follow-up of normal peripheral blood progenitor cell donors treated with filgrastim: no evidence of increased risk of leukemia development. Bone Marrow Transplant 2002;30:661-663.
70. Makita K, Ohta K, Mugitani A, Hagihara K, Ohta T, Yamane T, Hino M: Acute myelogenous leukemia in a donor after granulocyte colony-stimulating factor-primed peripheral blood stem cell harvest. Bone Marrow Transplant 2004;33:661-665.
71. Confer DL, Miller JP: Long-term safety of filgrastim (rhG-CSF) administration. Br J Haematol 2007;137:77-78.
72. Schmidt AH, Mengling T, Pingel J, Rall G, Ehninger G: Follow-up of 12,559 unrelated donors of peripheral blood stem cells or bone marrow. Blood 2010;116:abstr 365.
73. Germeshausen M, Ballmaier M, Welte K: Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: results of a long-term survey. Blood 2007;109:93-99.
74. Nagler A, Korenstein-Ilan A, Amiel A, Avivi L: Granulocyte colony-stimulating factor generates epigenetic and genetic alterations in lymphocytes of normal volunteer donors of stem cells. Exp Hematol 2004;32:122-130.
75. Hirsch B, Oseth L, Cain M, Trader E, Pulkrabek S, Lindgren B, Luo X, Clay M, Miller J, Confer D, Weisdorf D, McCullough J: Effects of granulocytecolony stimulating factor on chromosome aneuploidy and replication asynchrony in healthy peripheral blood stem cell donors. Blood 2011; 118:2602-2608.
76. Olnes MJ, Poon A, Miranda SJ, Pfannes L, Tucker Z, Loeliger K, Padilla-Nash H, Yau YY, Ried T, Leitman SF, Young NS, Sloand EM: Effects of granulocyte-colony-stimulating factor on monosomy 7 aneuploidy in healthy hematopoietic stem cell and granulocyte donors. Transfusion 2012;52: 537-541.
77. Shapira MY, Kaspler P, Samuel S, Shoshan S, Or R: Granulocyte colony stimulating factor does not induce long-term DNA instability in healthy peripheral blood stem cell donors. Am J Hematol 2003;73:33-36.
78. Hernandez JM, Castilla C, Gutierrez NC, Isidro IM, Delgado M, de las Rivas J, Ferminan E, Garcia JL, Ocio EM, del Canizo MC, San Miguel JF: Mobilisation with G-CSF in healthy donors promotes a high but temporal deregulation of genes. Leukemia 2005;19:1088-1091.
79. H lund M, Smedmyr B, Simonsson B, Totterman T, Bengtsson M: Dose-dependent mobilisation of haematopoietic progenitor cells in healthy volunteers receiving glycosylated rHuG-CSF. Bone Marrow Transplant 1996;18:19-27.
80. Hig K: Mobilisierung peripherer Blutstammzellen bei gesunden, allogenen Spendern-Effizienz und Vertr lichkeit. Habilitationsschrift, Medizinische Fakult Carl Gustav Carus der Technischen Universit Dresden, 2013.